Aida Pharmaceuticals, Inc.
AIDA · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8,399 | $6,117 | $3,129 | – |
| Short-Term Investments | $10,553 | $363 | $0 | – |
| Receivables | $10,831 | $16,638 | $13,714 | – |
| Inventory | $3,838 | $2,807 | $3,349 | – |
| Other Curr. Assets | $739 | $2,703 | $2,220 | – |
| Total Curr. Assets | $36,281 | $28,628 | $22,413 | – |
| Property Plant & Equip (Net) | $17,022 | $14,006 | $12,844 | – |
| Goodwill | $0 | $0 | $0 | – |
| Intangibles | $9,025 | $9,471 | $3,543 | – |
| Long-Term Investments | $0 | $0 | $0 | – |
| Tax Assets | $198 | $456 | $206 | – |
| Other NC Assets | $205 | $1,249 | $3,652 | – |
| Total NC Assets | $26,450 | $25,183 | $20,246 | – |
| Other Assets | $0 | $0 | $0 | – |
| Total Assets | $62,731 | $53,810 | $42,659 | – |
| Liabilities | – | – | – | – |
| Payables | $2,547 | $3,332 | $1,622 | – |
| Short-Term Debt | $31,721 | $27,660 | $21,451 | – |
| Tax Payable | $0 | $0 | $0 | – |
| Deferred Revenue | $144 | $173 | $106 | – |
| Other Curr. Liab. | $4,459 | $3,212 | $5,085 | – |
| Total Curr. Liab. | $38,871 | $34,377 | $28,265 | – |
| LT Debt | $1,647 | $5,638 | $3,717 | – |
| Deferred Rev, NC | $0 | $0 | $0 | – |
| Deferred Tax Liab, NC | $970 | $918 | $387 | – |
| Other NC Liab. | $55 | -$2,754 | $0 | – |
| Total NC Liab. | $2,672 | $3,904 | $4,105 | – |
| Other Liabilities | $0 | $0 | $0 | – |
| Cap. Leases | $0 | $0 | $0 | – |
| Total Liabilities | $41,543 | $38,281 | $32,370 | – |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | – |
| Common Stock | $27 | $27 | $150 | – |
| Retained Earnings | $7,330 | $4,590 | $3,136 | – |
| AOCI | $756 | $531 | $144 | – |
| Other Equity | $5,204 | $5,306 | $3,293 | – |
| Total Equity | $13,317 | $10,352 | $6,724 | – |
| Supplemental Information | – | – | – | – |
| Minority Interest | $7,871 | $5,177 | $3,565 | – |
| Total Liab. & Tot. Equity | $62,731 | $53,810 | $42,659 | – |
| Net Debt | $24,969 | $27,181 | $22,039 | $0 |